PL2101826T3 - Znakowane izotopowo związki na bazie peptydów i ich zastosowania - Google Patents

Znakowane izotopowo związki na bazie peptydów i ich zastosowania

Info

Publication number
PL2101826T3
PL2101826T3 PL07860908T PL07860908T PL2101826T3 PL 2101826 T3 PL2101826 T3 PL 2101826T3 PL 07860908 T PL07860908 T PL 07860908T PL 07860908 T PL07860908 T PL 07860908T PL 2101826 T3 PL2101826 T3 PL 2101826T3
Authority
PL
Poland
Prior art keywords
based compounds
peptide based
radiolabelled peptide
diseases
compounds
Prior art date
Application number
PL07860908T
Other languages
English (en)
Inventor
Torgrim Engell
Steven Fairway
Ingrid Henriksen
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of PL2101826T3 publication Critical patent/PL2101826T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/13—Labelling of peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PL07860908T 2006-12-11 2007-12-11 Znakowane izotopowo związki na bazie peptydów i ich zastosowania PL2101826T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86938206P 2006-12-11 2006-12-11
EP07860908A EP2101826B1 (en) 2006-12-11 2007-12-11 Radiolabelled peptide based compounds and uses thereof
PCT/NO2007/000434 WO2008072973A2 (en) 2006-12-11 2007-12-11 Radiolabelled peptide based compounds and uses thereof

Publications (1)

Publication Number Publication Date
PL2101826T3 true PL2101826T3 (pl) 2010-11-30

Family

ID=39252990

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07860908T PL2101826T3 (pl) 2006-12-11 2007-12-11 Znakowane izotopowo związki na bazie peptydów i ich zastosowania

Country Status (15)

Country Link
US (1) US20100322857A1 (pl)
EP (1) EP2101826B1 (pl)
JP (1) JP2010512310A (pl)
KR (1) KR20090097868A (pl)
CN (2) CN102321154A (pl)
AT (1) ATE471724T1 (pl)
AU (1) AU2007332210A1 (pl)
BR (1) BRPI0720257A2 (pl)
CA (1) CA2671564A1 (pl)
DE (1) DE602007007362D1 (pl)
ES (1) ES2346595T3 (pl)
MX (1) MX2009006028A (pl)
PL (1) PL2101826T3 (pl)
RU (1) RU2009119917A (pl)
WO (1) WO2008072973A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027584A1 (ja) * 2009-09-04 2011-03-10 国立大学法人京都大学 膵島イメージング用分子プローブ及びその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE188387T1 (de) * 1991-02-08 2000-01-15 Diatide Inc Technetium-99m markierte polypeptide zur bildformung
KR100866666B1 (ko) * 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
HU230901B1 (hu) * 2001-07-10 2019-01-28 Ge Healthcare Limited Peptidalapú vegyületek és ezeket tartalmazó gyógyszerkészítmények
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
NO20030115D0 (no) * 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods

Also Published As

Publication number Publication date
ATE471724T1 (de) 2010-07-15
DE602007007362D1 (de) 2010-08-05
BRPI0720257A2 (pt) 2014-02-25
MX2009006028A (es) 2009-06-17
CN102321154A (zh) 2012-01-18
CN101563108B (zh) 2012-07-18
CN101563108A (zh) 2009-10-21
US20100322857A1 (en) 2010-12-23
ES2346595T3 (es) 2010-10-18
KR20090097868A (ko) 2009-09-16
JP2010512310A (ja) 2010-04-22
CA2671564A1 (en) 2008-06-19
EP2101826A2 (en) 2009-09-23
AU2007332210A1 (en) 2008-06-19
EP2101826B1 (en) 2010-06-23
WO2008072973A2 (en) 2008-06-19
RU2009119917A (ru) 2011-01-20
WO2008072973A3 (en) 2009-05-22

Similar Documents

Publication Publication Date Title
DK1648925T3 (da) Bicyklisk peptid-billeddannende midler
Kuil et al. Imaging agents for the chemokine receptor 4 (CXCR4)
BR0210886A (pt) Composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
NO20071880L (no) Diagnostic Compounds
ATE519776T1 (de) Peptidische verbindungen
JP2009537624A5 (pl)
PT1472541E (pt) Agentes de imagiologia e métodos de imagiologia de naaladase de psma
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
EP1706145A4 (en) AUTOANTIC BODY USED IN TUMOR IMAGING AND CANCER TREATMENT AS A CARRIER FOR PHARMACEUTICAL COMPOUNDS
WO2001082864A3 (en) 18f-labeled choline analogs
Oliveira et al. Biomedical applications of radioiodinated peptides
BR9808509A (pt) Composições e métodos para o tratamento e diagnóstico do câncer de mama
Huang et al. Dual-modality micro-positron emission tomography/computed tomography and near-infrared fluorescence imaging of EphB4 in orthotopic glioblastoma xenograft models
WO2020103961A3 (zh) 一种脑部肿瘤靶向肽及其应用
GB0130305D0 (en) Compounds for imaging alzheimers disease
NZ591824A (en) Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
CN103998929A (zh) 选择患者的方法
MX2009006028A (es) Compuestos basados en peptido radiomarcado y usos de los mismos.
IL159479A0 (en) Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
BR0009573A (pt) Composições e métodos para o tratamento e diagnose do câncer de mama
Brogsitter et al. Twins in spirit: DOTATATE and high-affinity DOTATATE
DE60033697D1 (de) Radiomarkierte vip-analoge zur diagnose und therapie
NO20064232L (no) Alfa.emitterende hydroksyapatittparikler
AU2003247704A1 (en) Methods and compositions for diagnosing hepatocellular carcinoma
WO2024083224A8 (en) Dual receptor targeting radioligands and uses thereof